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Dental biofilms that form in the oral cavity play a critical role in the pathogenesis of several infectious oral diseases, including
dental caries, periodontal disease, and oral candidiasis. Houttuynia cordata (HC, Saururaceae) is a widely used traditional
medicine, for both internal and external application. A decoction of dried HC leaves (dHC) has long been consumed as a health-
promoting herbal tea in Japan. We have recently reported that a water solution of HC poultice ethanol extract (wHCP) exerts
antimicrobial and antibiofilm effects against several important oral pathogens. It also exhibits anti-inflammatory effects on human
keratinocytes. In our current study, we examined the effects of dHC on infectious oral pathogens and inflammation. Our results
demonstrated that dHC exertsmoderate antimicrobial effects againstmethicillin-resistant Staphylococcus aureus (MRSA) and other
oral microorganisms. dHC also exhibited antibiofilm effects against MRSA, Fusobacterium nucleatum (involved in dental plaque
formation), and Candida albicans and inhibitory effects on interleukin-8, CCL20, IP-10, and GRO𝛼 productions by human oral
keratinocytes stimulated by Porphyromonas gingivalis lipopolysaccharide (a cause of periodontal disease), without cytotoxic effects.
This suggests that dHCexhibitsmultiple activities inmicroorganisms andhost cells. dHCcan be easily prepared andmay be effective
in preventing infectious oral diseases.
1. Introduction
Dental biofilms that form in the oral cavity play a critical
role in the pathogenesis of numerous infectious oral diseases,
including periodontal disease. This can be due to the absorp-
tion of antimicrobial and antiseptic drugs and development
of resistance to host immune cells [1–3]. Predominant fungi
such asCandida albicans in the oral cavity can also contribute
to the development of infectious oral diseases ranging from
denture stomatitis [4, 5] to life-threatening invasive infec-
tions, including aspiration pneumonia. This is particularly
apparent in immunocompromised and elderly patients [6–8].
We have previously reported a higher prevalence of Candida
spp., Pseudomonas aeruginosa, and Staphylococcus spp. in
the oropharyngeal microflora of patients with cerebrovascu-
lar infarction and dysphagia [6]. Reducing adherence and
biofilm formation by oral microorganisms can contribute to
the prevention of chronic oral infections that may lead to
potentially severe, systemic opportunistic diseases, particu-
larly in the elderly [9, 10].
Oral keratinocytes play an important role as the first
physical barrier to bacterial invasion by organizing the local
innate immune system against colonizing microorganisms.
They also secrete several proinflammatory mediators (i.e.,
chemokines and cytokines) in response to various stimuli,
including microbial infections and chemical or thermal
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irritations [11–13]. These mediators ultimately cause perio-
dontal inflammation. Lipopolysaccharide (LPS) from Gram-
negative bacteria, such as the important periodontal patho-
gen Porphyromonas gingivalis, upregulates the production
of various proinflammatory mediators via signal cascades
in the gingival epithelium. These include interleukin-8 (IL-
8), CCL20, IFN-𝛾-inducible protein 10 (IP-10), and growth
related oncogene-𝛼 (GRO𝛼) [14–22]. Therefore, the devel-
opment of oral care products that reduce biofilm formation
and subsequent proinflammatory responses is essential for
improving health and preventing disease.
Previous studies have demonstrated that extracts from
medicinal plants exhibit various pharmacological activities
including antimicrobial effects [23–26], antiadherence effects
against oral microorganisms [27–29], and anti-inflammatory
effects [30–33]. Houttuynia cordata Thunb. (HC, Sauru-
raceae) is widely used as a traditional medicine, both inter-
nally and externally [34]. However, evidence to indicate
that HC extract exerts pharmacological effects against oral
microorganisms is limited. We have focused on identifying
and characterizing any activity of HC against infectious
diseases caused by oral microorganisms. We have recently
reported that a HC poultice ethanol extract (eHCP) exerted
antibacterial effects against cutaneous infection-related bac-
teria and anti-inflammatory effects on human keratinocytes
[34]. However, caution is required when suggesting that
eHCP could be applied to oral care because ethanol found in
mouthwashes has been suggested to increase the risk of oral
cancer [35].
Fortunately, we have also shown that a water solution of
eHCP (wHCP) exhibits antimicrobial and antibiofilm effects
on oral microorganisms and anti-inflammatory effects on
oral keratinocytes [36]. A decoction of dried HC leaves
(dHC), commonly consumed as a health-promoting herbal
tea in Japan, is simpler to prepare than wHCP. We therefore
examined the antimicrobial and antibiofilm effects of dHCon
several important infectious oral pathogens and investigated
the anti-inflammatory effects of dHC on P. gingivalis LPS-
stimulated human oral keratinocytes.
2. Material and Methods
2.1. Plant Materials and Sample Preparation. HC used in
this study was collected in Kochi City and identified by
Dr. K. Fujikawa (the Kochi Prefectural Makino Botanical
Garden, Kochi, Japan). Voucher specimens (FOS-007536,
FOS-007537, and FOS-010389) were also deposited here.
2.2. Preparation of dHC. dHC was prepared as follows: 3 g of
dried HC leaves was decocted with 130mL of sterile purified
water at 90–95∘C for 30min (EK-SA 10, ZOJIRUSHI, Osaka,
Japan). The decoction was then centrifuged for 15min at
1,500×g. After centrifugation, the clear supernatant layer was
filtered through a 0.45-𝜇mfilter and stored at 4∘C until being
assayed.
2.3. Flavonoid Glycosides. Quercitrin and rutin were pur-
chased from Sigma-Aldrich (St. Louis, MO) and Tokyo
Chemical Industry Co., Ltd. (Tokyo, Japan), respectively.
Table 1: Bacterial strains.
Strain Source
Methicillin-resistant Staphylococcus aureus T31 Clinical isolate
Methicillin-resistant Staphylococcus aureus COL Wild type
Streptococcus mutansMT8148 Clinical isolate
Streptococcus mutans UA159 Clinical isolate
Streptococcus sobrinus 1310 Clinical isolate
Streptococcus gordonii ATCC10558 Type strain
Streptococcus oralis ATCC10557 Type strain
Streptococcus constellatus 4528 Clinical isolate
Streptococcus intermedius 40138 Clinical isolate
Streptococcus mitis JCM 12971 Wild type
Aggregatibacter actinomycetemcomitans Y4 Wild type
Fusobacterium nucleatum JCM8532 Wild type
Porphyromonas gingivalis ATCC33277 Type strain
Pseudomonas aeruginosa PAO1 Wild type
Candida albicans CAD1 Clinical isolate
Isoquercitrin and hyperin were isolated from the aerial parts
of Hypericum sikokumountanum [37]. Flavonoid glycosides
were dissolved in dimethyl sulfoxide (DMSO, nacalai tesque,
Kyoto, Japan).
2.4. Bacterial Strains and Growth Conditions. The bacte-
rial strains used in this study are shown in Table 1. P.
aeruginosa was grown in Muller-Hinton broth (Becton
Dickinson, Sparks, MD, USA) that was supplemented with
50 𝜇g/mL CaCl
2
and 25𝜇g/mL MgCl
2
. Methicillin-resistant
Staphylococcus aureus (MRSA) strains were grown inMuller-
Hinton broth supplemented with 25𝜇g/mL CaCl
2
, 12.5 𝜇g/
mLMgCl
2
, and 2% NaCl [38]. Streptococcus spp. were grown
anaerobically in brain heart infusion (Becton Dickinson).
Fusobacterium nucleatum and P. gingivaliswere grown anaer-
obically in brain heart infusion supplemented with 5𝜇g/mL
hemin and 0.5 𝜇g/mL menadione. Aggregatibacter actino-
mycetemcomitans was grown anaerobically in Todd Hewitt
Broth (OXOID Ltd., Hampshire, UK). C. albicans was grown
in Sabouraud dextrose medium composed of 10 g/L peptone
and 40 g/L glucose. For biofilm formation assays, trypticase
soy broth (Becton Dickinson) supplemented with 5 𝜇g/mL
hemin and 0.5 𝜇g/mL menadione, trypticase soy broth
supplemented with 0.3% glucose, and yeast nitrogen base
mediumat pH7 containing 2.5mmol/LN-acetylglucosamine
[39] were used for F. nucleatum, MRSA-T31, and C. albicans,
respectively.
2.5. Susceptibility Assay. The minimum inhibitory concen-
tration (MIC) of dHC was assessed using a microbial broth
dilution method. Approximately 106 colony-forming units
(CFU)/mL of each bacterial culture were inoculated into
100 𝜇L of medium containing a twofold serial dilution of
dHC in 96-well plates (TPP, Trasadingen, Switzerland) and
incubated either anaerobically (for Streptococcus spp., A.
actinomycetemcomitans, F. nucleatum, and P. gingivalis) or
aerobically (for MRSA T31, MRSA COL, P. aeruginosa,
and C. albicans) at 37∘C for 20 or 48 h. The MIC was
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defined as the lowest concentration that showed no bacterial
growth.
2.6. Biofilm Formation Assay. A crystal violet biofilm assay
was performed to quantify the biofilm mass as previously
described [40]. A 2-𝜇L (107 CFU/mL) sample of MRSA
T31 or C. albicans CAD1 in the stationary phase or a 5-
𝜇L (107 CFU/mL) sample of F. nucleatum JCM8532 in the
stationary phase was transferred into a 96-well plate (Cell-
star, Greiner Bio-One, Frickenhausen, Germany) from the
primary 150 𝜇L suspensions of broth or media. dHC was
then added to a final concentration of 10%. Quercitrin, iso-
quercitrin, hyperin, and rutin were added to a final concen-
tration of 200𝜇g/mL. Bacterial suspensions were incubated
either anaerobically (for F. nucleatum) at 37∘C for 24 h or
aerobically (for MRSA T31 and C. albicans) at 37∘C for 6 and
24 h. For the positive control, 2 or 1 𝜇g/mL of cetylpyridinium
chloride (CPC) (Tokyo Chemical Industry Co., Ltd., Tokyo,
Japan) was used [41]. For the negative control, 10% distilled
H
2
O was used. After incubation, any biofilms that formed
were washed with purified water twice without disturbing
the adherent biofilm. They were then stained with 150𝜇L of
0.1% crystal violet at 25∘C for 10min. Excess staining was
removed by gentle washing with purified water. After drying,
stained biofilms were extracted from each well by adding
150 𝜇L of ethanol, and the absorbance of the extract from the
stained biofilm was measured at 595 nm using a microplate
reader (model 680; Bio-Rad Laboratories, Hercules, CA,
USA).
2.7. Cell Culture. RT-7 cells, an immortalized human kera-
tinocyte cell line kindly provided by Dr. Kamata (Hiroshima
University, Hiroshima, Japan) [42], were cultured in Kera-
tinocyte-SFM (Gibco BRL, Gaithersburg, MD, USA) sup-
plemented with 100U/mL penicillin and 100 𝜇g/mL strepto-
mycin (Gibco BRL), at 37∘C in a water-saturated atmosphere
of 95% air and 5% CO
2
. Confluent monolayers were cultured
with 1 𝜇g/mL P. gingivalis LPS (InvivoGen, San Diego, CA,
USA), with and without the addition of 1% dHC or 50 𝜇g/mL
of quercitrin, isoquercitrin, hyperin, or rutin.
2.8. Lactate Dehydrogenase (LDH) Cytotoxicity Assay. The
effects of dHC on cell cytotoxicity were assessed using a
LDH assay. Confluent RT-7 cell monolayers in a 24-well plate
were cultured in Keratinocyte-SFM medium supplemented
with 10% and 1% dHC at 37∘C for 24 h in a water-saturated
atmosphere of 95% air and 5% CO
2
. As a positive control,
RT-7 cells were treated with 0.1% Triton X-100 at 25∘C for
10min. In the cytotoxicity assay, the levels of LDH released
into the recovered cell culture supernatants were measured
using an LDH cytotoxicity assay kit (Cayman Chemical, Ann
Arbor, MI, USA) following the manufacturer’s instructions.
Absorbance was measured at 490 nm using a microplate
reader (Bio-Rad Laboratories).
2.9. Enzyme-Linked Immunosorbent Assay. Enzyme-linked
immunosorbent assay (ELISA) kits were used to quantify
the levels of IL-8, CCL20, IP-10, and GRO𝛼 (R&D Systems,
Minneapolis, MN, USA) in cell culture supernatants.
Table 2: MIC of dHC.
Bacterial strain MIC
(%)∗ (𝜇g/mL)
Methicillin-resistant Staphylococcus aureus T31 5 750
Methicillin-resistant Staphylococcus aureus COL 10 1500
Streptococcus mutansMT8148 >10 >1500
Streptococcus mutans UA159 >10 >1500
Streptococcus sobrinus 1310 >10 >1500
Streptococcus gordonii ATCC10558 >10 >1500
Streptococcus oralis ATCC10557 >10 >1500
Streptococcus constellatus 4528 >10 >1500
Streptococcus intermedius 40138 10 1500
Streptococcus mitis JCM 12921 10 1500
Aggregatibacter actinomycetemcomitans Y4 >10 >1500
Fusobacterium nucleatum JCM8532 2.5 375
Porphyromonas gingivalis ATCC33277 10 1500
Pseudomonas aeruginosa PAO1 >10 >1500
Candida albicans CAD1 >10 >1500
∗Concentration of dHC in medium v/v.
2.10. Statistical Analysis. All statistical analyses were per-
formed using an unpaired Student’s 𝑡-test. Differences were
considered significant when the probability value was less
than 5% (∗𝑃 < 0.05).
3. Results
3.1. Moderate Antimicrobial Effects of dHC. We examined the
antimicrobial effects of dHC against several oral microor-
ganisms. As shown in Table 2, dHC exerted a moderate
antimicrobial effect against MRSA T31, MRSA COL, S.
intermedius, S. mitis, F. nucleatum, and P. gingivalis (MIC;
375–1500 𝜇g/mL).
3.2. Antibiofilm Effects of dHC. We next investigated whether
dHC had any antibiofilm effects. In this experiment, we
used a culture of the MRSA T31 clinical isolate. This strain
was selected because MRSA T31 exhibits increased biofilm
formation compared to MRSA COL (data not shown). We
also examined F. nucleatum and C. albicans. Both of these
species form biofilms in the human oral cavity, including
on denture surfaces [43, 44]. A biofilm formation assay at 6
and 24 h revealed that 10% dHC significantly inhibited bio-
film formation by MRSA T31 (Figure 1(a)) and C. albicans
(Figure 1(b)). We also showed that 10% dHC significantly
inhibited 24-h biofilm formation by F. nucleatum (Fig-
ure 1(c)). In each experiment, 10% dHC did not affect the
growth of these microorganisms (data not shown). These
results revealed that dHC exhibits an antibiofilm effect
against MRSA T31, F. nucleatum, and C. albicans. However,
dHC did not exert any antibiofilm effects against S. mutans
MT8148, a cause of dental caries (data not shown). The
MICs of dHC against MRSA T31, F. nucleatum, and C.
albicans were 5% (750𝜇g/mL), 2.5% (375𝜇g/mL), and >10%
(>1500 𝜇g/mL), respectively. In the biofilm formation assay,
bacterial abundance was approximately 100-fold higher than
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Figure 1:Antibiofilm effects of dHC onMRSAT31, C. albicans, and F. nucleatum. Antibiofilm effects of a water decoction ofHouttuynia cordata
(dHC) on biofilm formation by MRSA T31 (a) and CAD1 (b) at 6 or 24 h. Antibiofilm effects of dHC on biofilm formation by F. nucleatum
JCM8532 (c) at 24 h. As a positive control, 2𝜇g/mL (for MRSA T31, F. nucleatum) or 1 𝜇g/mL (for CAD1) of cetylpyridinium chloride (CPC)
was used. A negative control of 10% distilledH
2
Owas used. ∗∗∗Significant differences between the indicated groups at𝑝 < 0.001. ∗∗Significant
differences between the indicated groups at 𝑝 < 0.01 using a Student’s 𝑡-test (𝑛 = 8).
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Table 3: MIC of flavonoid glycosides.
Bacterial strain MIC (𝜇g/mL)
Quercitrin Isoquercitrin Hyperin Rutin
Methicillin-resistant Staphylococcus aureus T31 >512 >512 >512 >512
Candida albicans CAD1 >512 >512 >512 >512
Fusobacterium nucleatum JCM8532 256 512 512 256
∗∗∗
LD
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 (
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/m
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80,000
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60,000
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40,000
30,000
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Control 1% dHC 10% dHC 0.1%
Triton X-100
Figure 2: No cytotoxic effects of dHC on oral keratinocytes. The
cytotoxic effects of dHC on RT-7 cells were assessed by a lactate
dehydrogenase (LDH) cytotoxicity assay. 0.1% Triton X-100 treat-
ment and gentle agitation at 25∘C for 10min were used as a positive
control. ∗∗∗Significant differences between the indicated groups at
𝑝 < 0.001 using a Student’s 𝑡-test (𝑛 = 4).
that in the MIC assay. We also observed that bacteria grew
despite high concentrations of dHC.
3.3. No Cytotoxic Effects of dHC on Oral Keratinocytes. To
investigate the cytotoxicity of dHC on oral keratinocytes, we
measured the levels of LDH released from RT-7 cells. As
shown in Figure 2, dHC did not exert any cytotoxic effects,
up to a concentration of 10%. These results suggest that dHC
could be applied to oral care.
3.4. Inhibitory Effects of dHC on Chemokine Production by
Oral Keratinocytes. We have previously demonstrated that
CCL20 produced by inflamed gingival epithelial cells appears
to be closely connected to the proinflammatory response
of the gingiva. This is due to an important regulatory role
in specific lymphocyte migration into diseased periodontal
tissue [15]. In addition, TLR2, a pattern recognition receptor
for LPS from Gram-negative bacteria such as P. gingivalis, is
strongly expressed in the pocket epithelium of periodontal
tissues with chronic periodontitis. This participates in a
signaling cascade that upregulates the production of IL-8,
IP-10, and GRO𝛼 [12, 14, 16–22, 45]. We therefore examined
whether dHC inhibits the production of IL-8, CCL20, IP-10,
and GRO𝛼 in RT-7 cells stimulated by P. gingivalis LPS. We
found that 1% dHC significantly inhibited IL-8, CCL20, IP-
10, and GRO𝛼 productions by RT-7 cells stimulated with P.
gingivalis LPS after 24 h (Figures 3(a), 3(b), 3(c), and 3(d)).
This suggests that dHCmay be clinically useful as an oral care
product to prevent the infectious oral inflammation that is
observed during periodontal disease.
3.5. Antibiofilm and Anti-Inflammatory Effects of Flavonoid
Glycosides. Previous reports have shown that the leaves
of HC contain flavonoid glycosides such as quercitrin,
isoquercitrin, hyperin, and rutin [46, 47]. In this study,
antibacterial, antibiofilm, and anti-inflammatory assays of
four flavonoid glycosides (quercitrin, isoquercitrin, hyperin,
and rutin) were performed. As shown in Table 3, these
flavonoid glycosides had little antibacterial activities. How-
ever, 200𝜇g/mL of quercitrin, isoquercitrin, and hyperin
significantly inhibited 24-h biofilm formation by MRSA T31
and F. nucleatum but rutin showed inhibitory effect of biofilm
formation only by MRSA T31 (Figures 4(a) and 4(c)). In
biofilm formation by C. albicans, we could not observe
antibiofilm effects by these flavonoid glycosides (Figure 4(b)).
Moreover, 50 𝜇g/mL of quercitrin, isoquercitrin, hyperin,
and rutin significantly inhibited CCL20, IP-10, and GRO𝛼
productions by RT-7 cells stimulated with P. gingivalis LPS
(Figures 5(b), 5(c), and 5(d)). In IL-8 production, suppressive
effect was observed only in rutin (Figure 5(a)).
4. Discussion
Our study has successfully demonstrated that dHC exerts a
moderate antimicrobial effect against microorganisms that
normally colonize the oral cavity (Table 2). We have also
shown that dHC exhibits antibiofilm effects against MRSA,
F. nucleatum, and C. albicans (Figures 1(a), 1(b), and 1(c)).
Finally, we have shown that dHC can inhibit IL-8 and
CCL20 production by P. gingivalis LPS-stimulated human
oral keratinocytes, with no apparent cytotoxic effects (Figures
2, 3(a), 3(b), 3(c), and 3(d)).
Previous studies have reported that medicinal plant
extracts can exert moderate antimicrobial effects against
oral microorganisms. These include a crude aqueous extract
of ripe Morinda citrifolia fruit (Indian noni), a methanol
extract of Polygonum cuspidatum, and a methanol extract of
Syzygium aromaticum (clove) [23–26]. However, it has been
suggested that the use of organic extracts that include ethanol
for oral care increases the risks of adverse reactions [35].
Therefore, a water solution of HC poultice ethanol extract
(wHCP) used in our study may be safer than the ethanol
based extract (eHCP) [36]. Our study has examined the
properties of dHC, which is simpler to prepare than wHCP
and has been used as health-promoting herbal tea without
any reported adverse reactions from our interview survey
[34, 36]. Previous studies have demonstrated that medicinal
6 Evidence-Based Complementary and Alternative Medicine
0
200
400
600
800
1000
1200
IL
-8
 (p
g/
m
L)
∗∗
Control
1.0% dHC 1.0% dHC——
P. gingivalis LPS (1 Ａ/mL)
(a)
0
100
200
300
400
500
600
700
800
CC
L2
0 
(p
g/
m
L)
∗∗
Control
1.0% dHC 1.0% dHC——
P. gingivalis LPS (1 Ａ/mL)
(b)
0
50
100
150
200
250
300
350
400
Control
IP
-1
0 
(p
g/
m
L)
∗
1.0% dHC 1.0% dHC——
P. gingivalis LPS (1 Ａ/mL)
(c)
Control
0
200
400
600
800
1000
1200
1400
1600
1.0% dHC 1.0% dHC
∗
G
RO

(p
g/
m
L)
——
P. gingivalis LPS (1 Ａ/mL)
(d)
Figure 3: Inhibitory effects of dHC on chemokine production by P. gingivalis LPS-stimulated oral keratinocytes. Inhibitory effects of a water
decoction of Houttuynia cordata (dHC) on IL-8 (a), CCL20 (b), IP-10 (c), and GRO𝛼 (d) production by oral keratinocytes stimulated with
P. gingivalis LPS for 24 h. ∗∗Significant differences between the indicated groups at 𝑝 < 0.01. ∗Significant differences between the indicated
groups at 𝑝 < 0.05 using a Student’s 𝑡-test (𝑛 = 6).
plants also exert antiadherence effects against oral microor-
ganisms [27–29]. In addition to a moderate antimicrobial
effect, our results have shown that dHC significantly inhibits
adherence after 6 h (Figures 1(a) and 1(b)) and biofilm forma-
tion byMRSA andC. albicans at 24 h (Figures 1(a) and 1(b)). It
also inhibited biofilm formation by F. nucleatum (Figure 1(c)).
Finally, HC has also been shown to have an effect on host
responses, with previous studies reporting that a 70% ethanol
extract of HC dried aerial parts inhibits the production of
several inflammatory biomarkers by lung epithelial cells,
including IL-6 and nitric oxide (NO), and HC also inhibited
lung inflammatory responses in a mouse model of LPS-
induced acute lung injury [32]. Furthermore, a HC ethanol
extract reduced the production of proinflammatory cytokines
through the NF-𝜅B signaling pathway in human mast cells
[31]. A water extract of HC has also been shown to exert
strong anti-inflammatory effects against S. aureus lipotei-
choic acid-induced inflammatory responses that are partly
attributed to the inhibition of tumor necrosis factor (TNF)
expression in dermal fibroblasts [30]. Finally, a powdered
extract of HC was recently found to modulate innate oral
immunemediators in oral epithelial cells [33], and themRNA
abundance of IL-8 and CCL20 (used as inflammatory media-
tors) was upregulated in a dose-dependentmanner. However,
our results demonstrated that dHC inhibited IL-8, CCL20,
IP-10, and GRO𝛼 production by P. gingivalis LPS-stimulated
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Figure 4: Antibiofilm effects of flavonoid glycosides on MRSA T31, C. albicans, and F. nucleatum. Antibiofilm effects of flavonoid glycosides
on biofilm formation by MRSA T31 (a), CAD1 (b), and F. nucleatum (c) at 24-h. A negative control of 2% DMSO was used. ∗∗∗Significant
differences between the indicated groups at 𝑝 < 0.001. ∗∗Significant differences between the indicated groups at 𝑝 < 0.01. ∗Significant
differences between the indicated groups at 𝑝 < 0.05 using a Student’s 𝑡-test (𝑛 = 4).
humanoral keratinocytes.This indicates that dHCcan exhibit
multiple different activities against microorganisms and host
cells and may be useful as an oral care product to prevent
infectious oral diseases.
Previous reports have shown that HC contains aldehydes,
such as capric aldehyde (decanal), lauryl aldehyde (dodec-
anal), and decanoyl acetaldehyde (3-oxo-dodecanal, hout-
tuynin), and flavonoid glycosides, such as quercitrin, isoquer-
citrin, hyperin, and rutin [46–49]. Aldehydes have antibac-
terial activity; however, the dried leaves of HC could not
contain aldehydes because of their instability and volatility.
This will be why the antimicrobial effects of dHCwere weaker
than those of wHCP. Conversely, the antibiofilm and anti-
inflammatory effects demonstrated by dHC were similar to
those of wHCP. This suggests that the antibiofilm and anti-
inflammatory constituents of dHC and wHCP would be
flavonoid glycosides.These effects of each flavonoid glycoside
are different with bacterial species and cytokines. The use
of dHC containing flavonoid glycosides represents a simpler
preparation method than wHCP for self-medication.
In Japan, aspiration pneumonia is a serious medical issue
in immunocompromised patients, particularly the elderly.
We have previously reported a higher prevalence of Candida
spp., P. aeruginosa, and Staphylococcus spp. in the oropha-
ryngeal microflora of patients with cerebrovascular infarc-
tion and dysphagia [6]. Reducing adherence and biofilm
formation by oral microorganisms can contribute to the
prevention of chronic oral infections and potentially severe,
systematic opportunistic diseases, particularly in the elderly
[9, 10]. Therefore, the use of dHC as herbal tea may strongly
contribute to the prevention of aspiration pneumonia.
Povidone iodine, chlorhexidine, and benzethonium chlo-
ride are typically used as antiseptic mouthwashes or rinses
to prevent oral infections including dental caries and peri-
odontal diseases [50–55]. However, these antiseptics exhibit
mucosal cytotoxicity, have a bad flavor, and can cause ana-
phylactic reactions [54, 56–58]. Therefore, dHC prepared as
herbal tea is likely a safer mouthwash than these antiseptics.
It also has a milder taste, without odor or cytotoxicity.
The results of our study contribute to the evaluation of
dHC as an effective herbal tea that may help prevent infec-
tious oral diseases. Further studies are needed to fully charac-
terize the constituents of dHC and identify the specific factors
that exhibit the antibiofilm and anti-inflammatory activities.
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Figure 5: Anti-inflammatory effects of flavonoid glycosides on chemokine production by P. gingivalis LPS-stimulated oral keratinocytes.
Inhibitory effects of flavonoid glycosides on IL-8 (a), CCL20 (b), IP-10 (c), and GRO𝛼 (d) productions by oral keratinocytes stimulated
with P. gingivalis LPS for 24 h. ∗∗∗Significant differences between the indicated groups at 𝑝 < 0.001. ∗∗Significant differences between the
indicated groups at 𝑝 < 0.01. ∗Significant differences between the indicated groups at 𝑝 < 0.05 using a Student’s 𝑡-test (𝑛 = 3).
5. Conclusion
This study demonstrated that dHC exerts amoderate antibac-
terial effect against MRSA and other microorganisms. It also
exhibited antibiofilm effects againstMRSA, F. nucleatum, and
C. albicans. We have shown that dHC exerts inhibitory effects
on IL-8 and CCL20 production by P. gingivalis LPS-stimu-
lated human oral keratinocytes, without cytotoxicity. Our
results suggest that dHC has multiple activities in microor-
ganisms and host cells and a herbal tea preparation may be
effective in preventing infectious oral diseases.
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